OIS at AAO 2015

Mati Therapeutics

Nov 12, 2015 8:54am ‐ Nov 12, 2015 9:02am


Description

Mati Therapeutics Inc. is developing an enhanced drug delivery platform to administer therapeutics to the eye. Due to Mati’s ability to adjust this platform, this technology can be used to treat a range of ophthalmic conditions with multiple therapies in late stage development.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content